Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alaka Deshpande

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|October 5, 2010
Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testingBharat B Rewari, Damodar Bachani, Sikhamani Rajasekaran, et al.
Global Health Action|August 3, 2014
Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, IndiaSamsuddin Khan, Mrinalini Das, Aristomo Andries, et al.
Journal of Medical Virology|March 18, 2011
Characterization of human immunodeficiency virus (HIV1C) variants in peripheral blood mononuclear cells and spermatozoaShivaji K Jadhav, Shilpa M Velhal, Alaka Deshpande, et al.
Human Vaccines & Immunotherapeutics|April 14, 2017
Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical studyGadey Sampath, Angelika Banzhoff, Alaka Deshpande, et al.
AIDS Research and Human Retroviruses|March 26, 2010
Analysis of RT sequences of subtype C HIV-type 1 isolates from indian patients at failure of a first-line treatment according to clinical and/or immunological WHO guidelinesAlaka Deshpande, Anne Cécile Jeannot, Marie Hélène Schrive, et al.
AIDS Research and Human Retroviruses|April 24, 2012
Susceptibility to etravirine of HIV type 1 subtype C isolates from nevirapine/efavirenz-experienced patients: comparative interpretation of ANRS and STANFORD algorithmsDelphine Anquetil, Alaka Deshpande, Drissa Zongo, et al.
AIDS (London, England)|June 26, 2003
IL-4 and CXCR4 upregulation in HIV-infected and uninfected individuals from Maharashtra-MumbaiMara Biasin, Adriano Boasso, Luca Piacentini, et al.
BMC Infectious Diseases|February 13, 2019
Immune signatures for HIV-1 and HIV-2 induced CD4<sup>+</sup>T cell dysregulation in an Indian cohortSukeshani Salwe, Amitkumar Singh, Varsha Padwal, et al.
AIDS Research and Human Retroviruses|March 3, 2007
Resistance mutations in subtype C HIV type 1 isolates from Indian patients of Mumbai receiving NRTIs plus NNRTIs and experiencing a treatment failure: resistance to ARAlaka Deshpande, Valérie Jauvin, Noel Magnin, et al.
AIDS Research and Human Retroviruses|December 9, 2004
Molecular characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutationsAlaka Deshpande, Patricia Recordon-Pinson, Ranjana Deshmukh, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Acquired Immune Deficiency Syndromes (1999)|October 5, 2010
Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testingBharat B Rewari, Damodar Bachani, Sikhamani Rajasekaran, et al.
Global Health Action|August 3, 2014
Second-line failure and first experience with third-line antiretroviral therapy in Mumbai, IndiaSamsuddin Khan, Mrinalini Das, Aristomo Andries, et al.
Journal of Medical Virology|March 18, 2011
Characterization of human immunodeficiency virus (HIV1C) variants in peripheral blood mononuclear cells and spermatozoaShivaji K Jadhav, Shilpa M Velhal, Alaka Deshpande, et al.
Human Vaccines & Immunotherapeutics|April 14, 2017
Comparison of the immunogenicity and safety of the purified chick embryo cell rabies vaccine manufactured in India and Germany: A randomized, single blind, multicentre, phase IV clinical studyGadey Sampath, Angelika Banzhoff, Alaka Deshpande, et al.
AIDS Research and Human Retroviruses|March 26, 2010
Analysis of RT sequences of subtype C HIV-type 1 isolates from indian patients at failure of a first-line treatment according to clinical and/or immunological WHO guidelinesAlaka Deshpande, Anne Cécile Jeannot, Marie Hélène Schrive, et al.
AIDS Research and Human Retroviruses|April 24, 2012
Susceptibility to etravirine of HIV type 1 subtype C isolates from nevirapine/efavirenz-experienced patients: comparative interpretation of ANRS and STANFORD algorithmsDelphine Anquetil, Alaka Deshpande, Drissa Zongo, et al.
AIDS (London, England)|June 26, 2003
IL-4 and CXCR4 upregulation in HIV-infected and uninfected individuals from Maharashtra-MumbaiMara Biasin, Adriano Boasso, Luca Piacentini, et al.
BMC Infectious Diseases|February 13, 2019
Immune signatures for HIV-1 and HIV-2 induced CD4<sup>+</sup>T cell dysregulation in an Indian cohortSukeshani Salwe, Amitkumar Singh, Varsha Padwal, et al.
AIDS Research and Human Retroviruses|March 3, 2007
Resistance mutations in subtype C HIV type 1 isolates from Indian patients of Mumbai receiving NRTIs plus NNRTIs and experiencing a treatment failure: resistance to ARAlaka Deshpande, Valérie Jauvin, Noel Magnin, et al.
AIDS Research and Human Retroviruses|December 9, 2004
Molecular characterization of HIV type 1 isolates from untreated patients of Mumbai (Bombay), India, and detection of rare resistance mutationsAlaka Deshpande, Patricia Recordon-Pinson, Ranjana Deshmukh, et al.
Pageof 3